301111.SZ
Get informed when a big investor buys or sells
+ FollowOvervalued by 92.4% based on the discounted cash flow analysis.
| Market cap | $3.34 Billion |
|---|---|
| Enterprise Value | $3.02 Billion |
| Dividend Yield | $0.05 (0.24%) |
| Earnings per Share | $-0.03 |
| Beta | 0.98 |
| Outstanding Shares | 160,000,000 |
| P/E Ratio | 566.4 |
|---|---|
| PEG | -208.45 |
| Price to Sales | 19.3 |
| Price to Book Ratio | 4.83 |
| Enterprise Value to Revenue | 9.9 |
| Enterprise Value to EBIT | -965.77 |
| Enterprise Value to Net Income | 508 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.06 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Guangdong Lifestrong Pharmacy Co., Ltd. is a pharmaceutical company primarily involved in the research, development, manufacturing, and sales of various medical products. Its extensive product range includes different dosage forms such a...